DeepMed Research

CHINA MEDICAL UNIVERSITY

🇹🇼Taiwan

Country: 🇹🇼Taiwan

Ownership: Private

Employees: -

Market Cap: -

Website: http://english.cmu.edu.tw

Clinical Trials

Effect of Lithium Carbonate on Postoperative Sleep and Cognitive Function in Patients Undergoing Heart Valve Surgery With Cardiopulmonary Bypass

Phase 4

Recruiting

Conditions: Heart Valve Surgery

Interventions: Drug: Lithium Carbonate 250 MG Oral Tablet
Drug: Calcium Carbonate 500 MG Oral Tablet

First Posted Date: 2022-10-25

Last Posted Date: 2023-07-18

Lead Sponsor: China Medical University, China

Target Recruit Count: 62

Registration Number: NCT05593627

Locations: 🇨🇳
the First Hospital of China Medical University, Shenyang, Liaoning, China

Anti-PD-1 Antibody Combined With Autologous DC and NK Cells in the Treatment of Digestive Carcinoma

Phase 2

Not yet recruiting

Conditions: Gastrointestinal Tumours
NK-Cell
PD-1 Antibody
DC-Cell

Interventions: Drug: Pembrolizumab
Drug: Nivolumab
Drug: Sintilimab
Drug: Toripalimab
Drug: Camrelizumab
Drug: Tislelizumab
Biological: NK-Cell or DC-Cell

First Posted Date: 2022-07-18

Last Posted Date: 2022-07-18

Lead Sponsor: China Medical University, China

Target Recruit Count: 1

Registration Number: NCT05461235

Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients

Phase 1

Not yet recruiting

Conditions: Regorafenib
Raltitrexed
Colorectal Neoplasms
Third-line Treatment

Interventions: Drug: Regorafenib
Drug: Raltitrexed

First Posted Date: 2022-06-22

Last Posted Date: 2022-06-29

Lead Sponsor: China Medical University, China

Target Recruit Count: 50

Registration Number: NCT05426811

Hemodynamic Management in Women With SHS

Not Applicable

Recruiting

Conditions: Supine Hypotensive Syndrome

Interventions: Procedure: LiDCOrapid

First Posted Date: 2022-04-22

Last Posted Date: 2023-03-07

Lead Sponsor: China Medical University, China

Target Recruit Count: 60

Registration Number: NCT05341362

Locations: 🇨🇳
China Medical University, Shenyang, Liaoning, China

Characterizations of Gut Microbiota and Postoperative Sleep in Patients Undergoing Heart Valve Surgery With Cardiopulmonary Bypass

Completed

Conditions: Heart Valve Surgery

First Posted Date: 2021-11-26

Last Posted Date: 2022-10-25

Lead Sponsor: China Medical University, China

Target Recruit Count: 36

Registration Number: NCT05136001

Locations: 🇨🇳
the First Hospital of China Medical University, Shenyang, Liaoning, China

the Effect of Trans-nasal Fixation of Endotracheal Tubes for Prone Ventilation

Not Applicable

Completed

Conditions: Prone Craniotomy
Endotracheal Intubation Fixation

Interventions: Device: SFC

First Posted Date: 2021-10-26

Last Posted Date: 2022-03-08

Lead Sponsor: China Medical University, China

Target Recruit Count: 30

Registration Number: NCT05093595

Locations: 🇨🇳
Yue Yun, Shenyang, Liaoning, China

A Phase II Study of Anti-PD-1 Antibody, Sintilimab, as Second-line Therapy for Biomarker-selected Advanced or Metastatic NSCLC

Phase 2

Conditions: Non-small Cell Lung Cancer

Interventions: Drug: Sintilimab

First Posted Date: 2020-11-03

Last Posted Date: 2020-11-03

Lead Sponsor: China Medical University, China

Target Recruit Count: 33

Registration Number: NCT04612673

Locations: 🇨🇳
The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China

Consistency Evaluation of the qCON, qNOX Indices and Bispectral Index

Not Applicable

Completed

Conditions: Electroencephalography
Anesthesia Monitor
Sleep

Interventions: Other: Bispectral index and qCON/qNOX monitoring

First Posted Date: 2020-09-24

Last Posted Date: 2021-11-09

Lead Sponsor: China Medical University, China

Target Recruit Count: 30

Registration Number: NCT04562181

Locations: 🇨🇳
Wen-fei Tan, Shenyang, Liaoning, China

Tyrosine Kinase Inhibitor (TKI) + Anti-PD-1 Antibody in TKI-responded Microsatellite Stability/Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Adenocarcinoma.

Phase 2

Conditions: MSS
pMMR
Metastatic Colorectal Adenocarcinoma

Interventions: Drug: TKI ± anti-PD-1 antibody

First Posted Date: 2020-07-23

Last Posted Date: 2021-10-05

Lead Sponsor: China Medical University, China

Target Recruit Count: 53

Registration Number: NCT04483219

Locations: 🇨🇳
Cancer Hospital of China Medical University/Liaoning Cancer Hospital &Institute, Shenyang, Liaoning, China

Effect of Lithium Carbonate on Postoperative Sleep in Patients Undergoing Videoassisted Thoracic Surgery

Phase 4

Completed

Conditions: Sleep Deprivation

Interventions: Drug: Calcium Carbonate 500 MG
Drug: Lithium Carbonate 250 MG

First Posted Date: 2020-07-21

Last Posted Date: 2022-02-04

Lead Sponsor: China Medical University, China

Target Recruit Count: 51

Registration Number: NCT04479566

Locations: 🇨🇳
the First Hospital of China Medical University, Shenyang, Liaoning, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy